Introduction
Overt and subclinical hypothyroidism have recently been recognized as the risk factors for a greater degree of coronary artery calcification [1, 2] . However, the real-world data on the clinical and subclinical hypothyroid status influencing the cardiovascular hemodynamics are limited. The impact of the hypothyroid state on the outcomes of percutaneous coronary interventions (PCI) specifically for the calcified coronary lesions subset have not been studied. There is a rise in the utilization of PCI with coronary atherectomy (CA) for complex lesions. Therefore, we decided to explore the outcomes of PCI with CA in hypothyroid patients using an inpatient database, the Nationwide Inpatient Sample (NIS). 
Materials And Methods
The NIS is the largest publicly accessible all-payer inpatient database in the United States (US) and is sponsored by the Agency for Healthcare Research and Quality as a part of the Healthcare Cost and Utilization Project [3] . The discharge weights were applied to attain the national estimates, which minimizes the margin of error representing over 95% of the US population. Table 1 ).
The propensity-matched (1:1) cohorts consisted of 827 (weighted N=4135) patients in both the groups. The proportions of age, sex, race, type of admission, location/teaching status of the hospital were comparable in both unmatched and propensity-matched cohorts. Similar to unmatched cohorts, hypertension, dyslipidemia, PVD, and COPD were more prevalent in the hypothyroid group after propensity matching ( Table 1) . However, the significant difference in the prevalence of diabetes with chronic complications between the two groups disappeared. In addition, the comorbidities uncomplicated diabetes (31.0% vs 27.8%, p=0.002) and coagulopathy (3.3% vs. 4.5%, p=0.004) were found to be more prevalent in the hypothyroid group after propensity score matching. In unmatched comparison, primary outcomes including all-cause in-hospital mortality (4.1% vs. 3.2%, p<0.01) and postoperative myocardial infarction rate (9.7% vs. 8.8%, p<0.05) were higher in the hypothyroid group as compared to the euthyroid group. However, there was no statistically significant difference in the incidence of any cardiac complications and postoperative stroke between the two groups. In addition, the hypothyroid group appeared to have a higher rate of other complications such as postoperative respiratory failure (1.6% vs. 0.9%, p<0.001) and acute kidney injury (AKI) requiring dialysis (1.3% vs. 0.8%, p<0.001) as compared to the euthyroid group. Secondary outcomes including LOS (days) (4.8±5.3 vs. 4.2±5.9, p<0.001) and total hospital charges (mean $116,379 vs. $107,711, p<0.001) were also higher in the hypothyroid group ( Table 1) .
Similar to unmatched analysis, propensity-matched analysis demonstrated significantly higher in-hospital mortality (4.1% vs. 1.0%. p<0.001), postoperative respiratory failure (1.7% vs. 0.5%, p<0.001), AKI requiring dialysis (1.2%, 0.6%, p<0.001), postoperative infection (2.5% vs. 1.3%, p<0.001), LOS (5.0±5.4 vs. 3.9±4.5, p<0.001), and total hospital charges (118,072±97,653 vs. 95,589±78,745, p<0.001) in the hypothyroid group. Although numerically higher in the hypothyroid group, there was no statistically significant difference in postoperative myocardial infarction incidence (9.8% vs. 8.7%, p=0.088) between the propensity-matched cohorts. Contrary to unmatched assessment, matched analysis revealed a higher incidence of any cardiac complications (12.2% vs. 10.5%, p=0.015) and postoperative infection (2.4% vs. 1.3%, p<0.001) in hypothyroid patients.
Discussion
Propensity-matched analysis demonstrated that the hypothyroid state is associated with higher risk of cardiovascular comorbidities, any cardiac complications, and all-cause in-hospital mortality, which is consistent with the previously published studies showing the negative impact of subclinical and clinical hypothyroidism on PCI outcomes [4, 5] . With a major strength of being performed on the largest inpatient sample in the US, our study also has a few potential limitations. As with any large database, there is a scope of administrative coding errors. Since the database does not provide the exact number of thyroid hormone levels, it is not possible to assess the strength of association for causality and establish the association between subclinical hypothyroidism and the worse outcomes.
Conclusions
In conclusion, by using propensity-matched analysis in the largest US database, we discovered that hypothyroidism was significantly associated to higher cardiovascular comorbidities, LOS, total hospital charges, cardiovascular complications, postoperative respiratory failure, AKI requiring dialysis, postoperative infection, and all-cause in-hospital mortality in the patients undergoing PCI with CA. Therefore, it is recommended that health care professionals be extra vigilant for the development of these complications in patients with hypothyroidism undergoing PCI with CA. Categorization of these patients as "high-risk" may help in the early recognition and management of these complications and curb higher cardiovascular morbidity and mortality in this population.
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